Clinical trial
Clinical Evaluation of the Residual Antimicrobial Activity of One Test Product Based on the ASTM E2752 Test Method
NCT04495920 is registered in ClinicalTrials.gov with CAGE Bio Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Evaluation of the Residual Antimicrobial Activity of One Test Product Based on the ASTM E2752 Test Method
- Lead sponsor
- CAGE Bio Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 16, 2020
- Completion date
- July 28, 2020
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bacterial overgrowth